The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease (COPD) in an Italian Context of Real Life: The TRITRIAL Study Protocol

BACKGROUND: The fixed triple combination Beclometasone dipropionate/Formoterol fumarate/Glycopyrronium (BDP/FF/G, Trimbow(®)), an extrafine formulation in a unique pressurized metered dose inhaler, is indicated for the maintenance treatment in adult patients with moderate to severe COPD, not adequat...

Descripción completa

Detalles Bibliográficos
Autores principales: Richeldi, Luca, Piraino, Alessio, Macagno, Francesco, Micarelli, Gianluigi, Ingrassia, Eleonora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850441/
https://www.ncbi.nlm.nih.gov/pubmed/33536751
http://dx.doi.org/10.2147/COPD.S286559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850441/
https://www.ncbi.nlm.nih.gov/pubmed/33536751
http://dx.doi.org/10.2147/COPD.S286559

Ejemplares similares